On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.

The global Skin Cancer Diagnostics and Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.

This report aims to provide a comprehensive presentation of the global market for Skin Cancer Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Diagnostics and Therapeutics.

Report Scope

The Skin Cancer Diagnostics and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Cancer Diagnostics and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Skin Cancer Diagnostics and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Skin Cancer Diagnostics and Therapeutics Market Report

Report Metric	Details
Report Name	Skin Cancer Diagnostics and Therapeutics Market
Segment by Type	Basal Cell Carcinoma Squamous Cell Carcinoma Melanoma
Segment by Application	Hospital Clinic Cancer Research Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Merck, Novartis, Pfizer, Qiagen, Roche, Sanofi, Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Cancer Diagnostics and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Skin Cancer Diagnostics and Therapeutics Market report?

Ans: The main players in the Skin Cancer Diagnostics and Therapeutics Market are GlaxoSmithKline, Merck, Novartis, Pfizer, Qiagen, Roche, Sanofi, Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly

What are the Application segmentation covered in the Skin Cancer Diagnostics and Therapeutics Market report?

Ans: The Applications covered in the Skin Cancer Diagnostics and Therapeutics Market report are Hospital, Clinic, Cancer Research Center, Others

What are the Type segmentation covered in the Skin Cancer Diagnostics and Therapeutics Market report?

Ans: The Types covered in the Skin Cancer Diagnostics and Therapeutics Market report are Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Basal Cell Carcinoma

1.2.3 Squamous Cell Carcinoma

1.2.4 Melanoma

1.3 Market by Application

1.3.1 Global Skin Cancer Diagnostics and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Cancer Research Center

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Skin Cancer Diagnostics and Therapeutics Market Perspective (2019-2030)

2.2 Skin Cancer Diagnostics and Therapeutics Growth Trends by Region

2.2.1 Global Skin Cancer Diagnostics and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Skin Cancer Diagnostics and Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Skin Cancer Diagnostics and Therapeutics Market Dynamics

2.3.1 Skin Cancer Diagnostics and Therapeutics Industry Trends

2.3.2 Skin Cancer Diagnostics and Therapeutics Market Drivers

2.3.3 Skin Cancer Diagnostics and Therapeutics Market Challenges

2.3.4 Skin Cancer Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Skin Cancer Diagnostics and Therapeutics Players by Revenue

3.1.1 Global Top Skin Cancer Diagnostics and Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Skin Cancer Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Skin Cancer Diagnostics and Therapeutics Revenue

3.4 Global Skin Cancer Diagnostics and Therapeutics Market Concentration Ratio

3.4.1 Global Skin Cancer Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Diagnostics and Therapeutics Revenue in 2023

3.5 Skin Cancer Diagnostics and Therapeutics Key Players Head office and Area Served

3.6 Key Players Skin Cancer Diagnostics and Therapeutics Product Solution and Service

3.7 Date of Enter into Skin Cancer Diagnostics and Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Cancer Diagnostics and Therapeutics Breakdown Data by Type

4.1 Global Skin Cancer Diagnostics and Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Type (2025-2030)

5 Skin Cancer Diagnostics and Therapeutics Breakdown Data by Application

5.1 Global Skin Cancer Diagnostics and Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Skin Cancer Diagnostics and Therapeutics Market Size (2019-2030)

6.2 North America Skin Cancer Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024)

6.4 North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Skin Cancer Diagnostics and Therapeutics Market Size (2019-2030)

7.2 Europe Skin Cancer Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024)

7.4 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Skin Cancer Diagnostics and Therapeutics Market Size (2019-2030)

9.2 Latin America Skin Cancer Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Introduction

11.1.4 GlaxoSmithKline Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Skin Cancer Diagnostics and Therapeutics Introduction

11.2.4 Merck Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.2.5 Merck Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Skin Cancer Diagnostics and Therapeutics Introduction

11.3.4 Novartis Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Skin Cancer Diagnostics and Therapeutics Introduction

11.4.4 Pfizer Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.4.5 Pfizer Recent Development

11.5 Qiagen

11.5.1 Qiagen Company Detail

11.5.2 Qiagen Business Overview

11.5.3 Qiagen Skin Cancer Diagnostics and Therapeutics Introduction

11.5.4 Qiagen Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.5.5 Qiagen Recent Development

11.6 Roche

11.6.1 Roche Company Detail

11.6.2 Roche Business Overview

11.6.3 Roche Skin Cancer Diagnostics and Therapeutics Introduction

11.6.4 Roche Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.6.5 Roche Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Skin Cancer Diagnostics and Therapeutics Introduction

11.7.4 Sanofi Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.7.5 Sanofi Recent Development

11.8 Abbott

11.8.1 Abbott Company Detail

11.8.2 Abbott Business Overview

11.8.3 Abbott Skin Cancer Diagnostics and Therapeutics Introduction

11.8.4 Abbott Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.8.5 Abbott Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Detail

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Skin Cancer Diagnostics and Therapeutics Introduction

11.9.4 AstraZeneca Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.9.5 AstraZeneca Recent Development

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Detail

11.10.2 Bristol-Myers Squibb Business Overview

11.10.3 Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Introduction

11.10.4 Bristol-Myers Squibb Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.10.5 Bristol-Myers Squibb Recent Development

11.11 Eli Lilly

11.11.1 Eli Lilly Company Detail

11.11.2 Eli Lilly Business Overview

11.11.3 Eli Lilly Skin Cancer Diagnostics and Therapeutics Introduction

11.11.4 Eli Lilly Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

11.11.5 Eli Lilly Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Basal Cell Carcinoma

Table 3. Key Players of Squamous Cell Carcinoma

Table 4. Key Players of Melanoma

Table 5. Global Skin Cancer Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Skin Cancer Diagnostics and Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Skin Cancer Diagnostics and Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Skin Cancer Diagnostics and Therapeutics Market Share by Region (2019-2024)

Table 9. Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Skin Cancer Diagnostics and Therapeutics Market Share by Region (2025-2030)

Table 11. Skin Cancer Diagnostics and Therapeutics Market Trends

Table 12. Skin Cancer Diagnostics and Therapeutics Market Drivers

Table 13. Skin Cancer Diagnostics and Therapeutics Market Challenges

Table 14. Skin Cancer Diagnostics and Therapeutics Market Restraints

Table 15. Global Skin Cancer Diagnostics and Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Skin Cancer Diagnostics and Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Skin Cancer Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnostics and Therapeutics as of 2023)

Table 18. Ranking of Global Top Skin Cancer Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Skin Cancer Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Skin Cancer Diagnostics and Therapeutics Product Solution and Service

Table 22. Date of Enter into Skin Cancer Diagnostics and Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Skin Cancer Diagnostics and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Skin Cancer Diagnostics and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. GlaxoSmithKline Company Detail

Table 48. GlaxoSmithKline Business Overview

Table 49. GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Product

Table 50. GlaxoSmithKline Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 51. GlaxoSmithKline Recent Development

Table 52. Merck Company Detail

Table 53. Merck Business Overview

Table 54. Merck Skin Cancer Diagnostics and Therapeutics Product

Table 55. Merck Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Skin Cancer Diagnostics and Therapeutics Product

Table 60. Novartis Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Pfizer Company Detail

Table 63. Pfizer Business Overview

Table 64. Pfizer Skin Cancer Diagnostics and Therapeutics Product

Table 65. Pfizer Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Pfizer Recent Development

Table 67. Qiagen Company Detail

Table 68. Qiagen Business Overview

Table 69. Qiagen Skin Cancer Diagnostics and Therapeutics Product

Table 70. Qiagen Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Qiagen Recent Development

Table 72. Roche Company Detail

Table 73. Roche Business Overview

Table 74. Roche Skin Cancer Diagnostics and Therapeutics Product

Table 75. Roche Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Roche Recent Development

Table 77. Sanofi Company Detail

Table 78. Sanofi Business Overview

Table 79. Sanofi Skin Cancer Diagnostics and Therapeutics Product

Table 80. Sanofi Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 81. Sanofi Recent Development

Table 82. Abbott Company Detail

Table 83. Abbott Business Overview

Table 84. Abbott Skin Cancer Diagnostics and Therapeutics Product

Table 85. Abbott Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Abbott Recent Development

Table 87. AstraZeneca Company Detail

Table 88. AstraZeneca Business Overview

Table 89. AstraZeneca Skin Cancer Diagnostics and Therapeutics Product

Table 90. AstraZeneca Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 91. AstraZeneca Recent Development

Table 92. Bristol-Myers Squibb Company Detail

Table 93. Bristol-Myers Squibb Business Overview

Table 94. Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Product

Table 95. Bristol-Myers Squibb Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 96. Bristol-Myers Squibb Recent Development

Table 97. Eli Lilly Company Detail

Table 98. Eli Lilly Business Overview

Table 99. Eli Lilly Skin Cancer Diagnostics and Therapeutics Product

Table 100. Eli Lilly Revenue in Skin Cancer Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)

Table 101. Eli Lilly Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Skin Cancer Diagnostics and Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Skin Cancer Diagnostics and Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Basal Cell Carcinoma Features

Figure 4. Squamous Cell Carcinoma Features

Figure 5. Melanoma Features

Figure 6. Global Skin Cancer Diagnostics and Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Skin Cancer Diagnostics and Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Cancer Research Center Case Studies

Figure 11. Others Case Studies

Figure 12. Skin Cancer Diagnostics and Therapeutics Report Years Considered

Figure 13. Global Skin Cancer Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Skin Cancer Diagnostics and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Skin Cancer Diagnostics and Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Skin Cancer Diagnostics and Therapeutics Market Share by Players in 2023

Figure 17. Global Top Skin Cancer Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnostics and Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Skin Cancer Diagnostics and Therapeutics Revenue in 2023

Figure 19. North America Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Skin Cancer Diagnostics and Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Skin Cancer Diagnostics and Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Share by Region (2019-2030)

Figure 33. China Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Skin Cancer Diagnostics and Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 48. Merck Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 49. Novartis Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 51. Qiagen Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 52. Roche Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 53. Sanofi Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 54. Abbott Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 55. AstraZeneca Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 57. Eli Lilly Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions